The Role of Bortezomib in the Treatment of Lymphoma

Author： Barr Paul   Fisher Richard   Friedberg Jonathan  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.25, Iss.8, 2007-11, pp. : 766-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bortezomib in mantle cell lymphoma

By Suh K Stephen   Goy Andre  

Future Oncology, Vol. 4, Iss. 2, 2008-04 ,pp. : 149-168

Future Medicine

Access to resources Recommend Favorite

Bortezomib: a proteasome inhibitor with an evolving role in select subtypes of B-cell non-Hodgkin’’s lymphoma

By Koprivnikar Jamie L   Cheson Bruce D  

Future Oncology, Vol. 8, Iss. 4, 2012-04 ,pp. : 359-371

Future Medicine

Access to resources Recommend Favorite

Bortezomib-based treatment for relapsed and refractory angioimmunoblastic T-cell lymphoma: Case report and literature review

By Liu Shuyan   Yuan Zhengang   Zhang Chunyang   Fu Weijun   Hou Jian  

Oncology Letters, Vol. 4, Iss. 2, 2012-08 ,pp. : 262-264

Spandidos Publications

Access to resources Recommend Favorite

Bortezomib in the Treatment of Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 397-403

Bentham Science Publishers

Access to resources Recommend Favorite

Role of radiotherapy in the treatment of primary mediastinal large Bcell lymphoma

By            

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2925-2930

Spandidos Publications

Access to resources Recommend Favorite